Recap: Century Therapeutics Q3 Earnings

Century Therapeutics (NASDAQ:IPSC) reported its Q3 earnings results on Thursday, November 9, 2023 at 07:00 AM.

Here's what investors need to know about the announcement.

Century Therapeutics missed estimated earnings by 7.84%, reporting an EPS of $-0.55 versus an estimate of $-0.51.

Revenue was down $2.08 million from the same period last year.

Last quarter the company missed on EPS by $0.02 which was followed by a 4.91% drop in the share price the next day.

Here's a look at Century Therapeutics's past performance:

Quarter	Q2 2023	Q1 2023	Q4 2022	Q3 2022
EPS Estimate	-0.54	-0.52	-0.59	-0.59
EPS Actual	-0.56	-0.53	-0.55	-0.53
Revenue Estimate	1.14M	1.31M	1.97M	1.13M
Revenue Actual	99K	1.72M	521K	2.22M

** Listen to the earnings announcement yourself by clicking here. **

To track all earnings releases for Century Therapeutics visit their earnings calendar here.

This article was generated by Benzinga's automated content engine and reviewed by an editor.